Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Bone. 2015 Apr 10;81:733–738. doi: 10.1016/j.bone.2015.03.013

Table 1.

Transcripcion-associated covalent histone modifications

Residue Modification Relation with gene expression Localization
Histone H3
K4 me1 Inactive or active [74] Widespread[75]; Enhancers[74, 76]
me2 Active[77, 78] TSS[75]
me3 Active[7580]; Inactive(Poised)[81, 82] TSS[75, 76, 80]
R8 Me Inactive [83, 84]
K9 Ac Active[75, 77, 79, 80, 8587] TSS[75, 80, 85]
me3 Inactive[79, 82, 88, 89] Heterochromatin [90]
S10 P Active[91, 92] TSS [92]
K14 Ac Active[75, 77, 8587] TSS[75, 85]
K16 Ac Active[79]
R17 me1/me2-asym Active [93]
K18 Ac Active[87, 93]
K20 me1 Inactive [88]
K23 Ac Active[87, 93]
K27 Ac Active [74] Enhancer [74]
me3 Inactive[79, 81, 82, 88, 89]
K36 me3 Active[80, 82, 85]; Hallmark of elongation[79, 85] Coding[80]
K79 me1 Inactive[94] TSS or Intergenic[94]
me2 Active[94] Coding[80]; TSS[94]
me3 Active[94] TSS[94]
Histone H4
R3 me2 (sym) Inactive[83, 95, 96] TSS[95]
K5/K8/K12/K16 Ac Active[78] Widespread[75]
K20 me3 Inactive [82]

Abbreviations: ac: acetylation; K: lysine residues; me: methylation, where me1, 2, 3 denotes mono-, di-, or trimethylation; P: phosphorylation; R: arginine residue; (a) sym: (a) symmetrical; TSS: Transcription Start Site